NOVEKO INTERNATIONAL INC. announced the signature of a License and Supply Agreement with MICROBAN INTERNATIONAL, LTD.

    Symbol: EKO / TSX

    MONTREAL, Aug. 11 /CNW Telbec/ - Noveko International Inc. ("the
Company") is pleased to announce that further to the preliminary discussions
previously announced on March 24, 2009, its subsidiary Noveko Trading 2008 LLC
("Noveko Trading") has entered into a License and Supply Agreement with
Microban International, Ltd. ("Microban"), the global leader in built-in
antimicrobial product protection, engineering durable antimicrobial solutions
for consumer, industrial and healthcare products around the world.
    Under the terms of this agreement, Microban has granted Noveko the right
to sell its line of AZURO(TM) hand sanitizers under the Microban(R) brand
name. This global agreement also grants Noveko the right to use the Microban
brand as the lead/host brand or ingredient brand, and the right and licence to
use the Microban antimicrobial technology and Microban's proprietary
antimicrobial additives, in the manufacture of the Noveko's surgical masks and
respirators through December 31, 2012.
    "We have made a crucial strategic decision by choosing Microban as a
partner. Through this agreement, we will gain access to the expertise and
reputation of a worldwide leader in the antimicrobial market which will allow
us to optimize our products - both in performance and in cost. Combining the
AZURO(TM) hand sanitizer quality and performance with the Microban brand name
will further accelerate our global market penetration in all segments,"
indicated Alain Bolduc, President and Chief Operating Officer of the Company.
    David Meyers, President and CEO of Microban International says, "Microban
antimicrobial technology provides a strong benefit for these product
applications and we are happy to partner with Noveko to bring a range of
innovative new products to market under the Microban brand name, especially
during a time when consumer concerns about the presence of microbes are
extremely high."


    Microban International, Ltd. is a global technology and marketing company
dedicated to enhancing high quality consumer, industrial and healthcare
products with branded built-in protection from microbes. Microban
International licenses the Microban (R) global brand name, sells
custom-engineered compounds, and provides a range of services, including
regulatory and marketing support. The Microban (R) brand promises continuous
and durable antimicrobial product protection, built-in during manufacture to
not wear out for the useful life of the product. Microban International is
headquartered in North Carolina with operations in North America, Europe and
Asia. For more information on Microban, please contact (704) 875-0806 or visit

    Noveko International Inc. offers innovative solutions in the
environmental and medical fields worldwide. Through its subsidiaries, the
Company specializes primarily in the following business segments: the
development, manufacturing and marketing of derivative products from its
patented antimicrobial filtration technology, including air filters, surgical
masks and respirators, along with other products with antimicrobial properties
such as AZURO (TM) hand sanitizers - and the development, manufacturing and
marketing of medical equipment, primarily portable real-time ultrasound
scanners for use in human and veterinary medicine.

    Certain statements set forth in this press release constitute
forward-looking statements. In some cases, these statements are identified by
the use of terms such as "may", "could", "might", "intend", "should",
"expect", "project", "plan", "believe", "estimate" or other comparable
variants. These statements are based on the information available at the time
they are written, on assumptions made by management and on the expectations of
management, acting in good faith, regarding future events, including those
relating to economic conditions, fluctuations in exchange rates and operating
expenses, and the absence of unusual events entailing supplementary
expenditures. Although management considers these assumptions and expectations
reasonable based on the information available at the time they are written,
they could prove inaccurate. Forward-looking statements are also subject, by
their very nature, to known and unknown risks and uncertainties such as those
related to the industry, acquisitions, labor relations, credit, key officers,
supply and product liability. The actual results of Noveko International Inc.
could differ materially from those indicated or underlying these
forward-looking statements. The reader is therefore recommended not to unduly
rely on these forward-looking statements. Forward-looking statements do not
reflect the potential impact of special items, any business combination or any
other transaction that may be announced or occur subsequent to the date
hereof. The Company undertakes no obligation to update or revise the
forward-looking statements to account for new events or new circumstances,
except where provided for by applicable legislation.

For further information:

For further information: Chantal Vennat, Director, Investor Relations
and Corporate Communications, Noveko International Inc., (514) 875-0606;

Organization Profile

Noveko International Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890